CFTR, mucins, and mucus obstruction in cystic fibrosis

Cold Spring Harbor Perspectives in Medicine

Volumn 2, Issue 9, 2012, Pages

  Kreda, Silvia M ^a   Davis, C William ^a,b   Rose, Mary Callaghan ^c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPITHELIAL SODIUM CHANNEL; EPITHELIAL SODIUM CHANNEL BETA SUBUNIT; ERYTHROMYCIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; MEMBRANE PROTEIN; MESSENGER RNA; MUCIN; MUCIN 1; MUCIN 19; MUCIN 2; MUCIN 5AC; MUCIN 5B; MUCIN 6; MUNC13 PROTEIN; Q SNARE PROTEIN; RHO KINASE; SYNAPTOSOMAL ASSOCIATED PROTEIN 23; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; TELITHROMYCIN; UNCLASSIFIED DRUG; GLYCOPROTEIN; MUC5AC PROTEIN, HUMAN;

AIRWAY OBSTRUCTION; ARTICLE; CYSTIC FIBROSIS; GASTROINTESTINAL TRACT; GENE CONTROL; GENE EXPRESSION; GENE REPRESSION; GENITAL SYSTEM; GOBLET CELL; HUMAN; IMMUNOLOCALIZATION; INFLAMMATION; LOWER RESPIRATORY TRACT; LUNG; MUCUS; NONHUMAN; PROTEIN ASSEMBLY; PROTEIN GLYCOSYLATION; PROTEIN SYNTHESIS; SECRETION (PROCESS); TRANSCRIPTION REGULATION; UPPER RESPIRATORY TRACT; ANIMAL; BIOSYNTHESIS; CHEMISTRY; DISEASE MODEL; FEMALE; GENE EXPRESSION REGULATION; GENETICS; GLYCOSYLATION; MALE; METABOLISM; MOUSE; PHYSIOLOGY; PNEUMONIA; REVIEW;

AIRWAY OBSTRUCTION; ANIMALS; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DISEASE MODELS, ANIMAL; FEMALE; GASTROINTESTINAL TRACT; GENE EXPRESSION REGULATION; GENITALIA; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; LUNG; MALE; MICE; MUCIN 5AC; MUCINS; MUCUS; PNEUMONIA; RNA, MESSENGER;

EID: 84879285251     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a009589     Document Type: Article

References (255)

1. 2+activation of mucin secretion in airway goblet cells. Am J Physiol 273: L201-L210.
2. Abdullah LH, Wolber C, Kesimer M, Sheehan JK, Davis CW. 2012. Studying mucin secretion from human bronchial epithelial cell primary cultures. Methods Mol Biol 842: 259-277.
3. Ajonuma LC, Ng EH, Chow PH, Hung CY, Tsang LL, Cheung AN, Brito-Jones C, Lok IH, Haines J, Chan HC. 2005. Increased cystic fibrosis transmembrane conductance regulator (CFTR) expression in the human hydrosalpinx. Hum Reprod 20: 1228-1234.
4. Allen A, Hutton DA, Pearson JP, Sellers LA. 1984. Mucus glycoprotein structure, gel formation and gastrointestinal mucus function. Ciba Found Symp 109: 137-156.
5. Ambort D, Johansson MEV, Gustafsson JK, Ermund A, Hansson GC. 2012. Perspectives on mucus properties and formation-lessons from the biochemical world. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a014159.
6. Andersch-Bjorkman Y, Thomsson KA, Holmen Larsson JM, Ekerhovd E, HanssonGC. 2007. Large scale identification of proteins, mucins, and their O-glycosylation in the endocervical mucus during the menstrual cycle. Mol Cell Proteomics 6: 708-716.
7. Anderson DH. 1938. Cystic fibrosis of the pancreas and its relation to celiac disease: A clinical and pathological study. Am J Dis Child 56: 344-399.
8. Ballard ST, Inglis SK. 2004. Liquid secretion properties of airway submucosal glands. J Physiol 556: 1-10.
9. Ballard ST, Spadafora D. 2007. Fluid secretion by submucosal glands of the tracheobronchial airways. Respir Physiol Neurobiol 159: 271-277.
10. Barasch J, al-Awqati Q. 1993. Defective acidification of the biosynthetic pathway in cystic fibrosis. J Cell Sci Suppl 17: 229-233.
11. Barasch J, Kiss B, Prince A, Saiman L, Gruenert D, al-Awqati Q. 1991. Defective acidification of intracellular organelles in cystic fibrosis. Nature 352: 70-73.
12. Bautista MV, Chen Y, Ivanova VS, Rahimi MK, Watson AM, Rose MC. 2009. IL-8 regulates mucin gene expression at the posttranscriptional level in lung epithelial cells. J Immunol 183: 2159-2166.
13. Bell SL, Xu G, Forstner JF. 2001. Role of the cystine-knot motif at the C-terminus of rat mucin protein Muc2 in dimer formation and secretion. Biochem J357: 203-209.
14. Best JA, Quinton PM. 2005. Salivary secretion assay for drug efficacy for cystic fibrosis in mice. Exp Physiol 90: 189-193.
15. Boat TF, Cheng PW, Wood RE. 1976. Tracheobronchial mucus secretion in vivo and in vitro by epithelial tissues from cystic fibrosis and control subjects. Mod Probl Paediatr 19: 141-152.
16. Boat TF, Welsh MJ, Beaudet AL. 1989. Cystic fibrosis. In The metabolic basis of inherited disease (ed. CR Scriver, et al.), pp. 2649-2680. McGraw-Hill, New York.
17. Boucher RC. 2007. Cystic fibrosis: A disease of vulnerability to airway surface dehydration. Trends Mol Med 13: 231-240.
18. Bove PF, Grubb BR, Okada SF, Ribeiro CM, Rogers TD, Randell SH, O'Neal WK, Boucher RC. 2010. Human alveolar type II cells secrete and absorb liquid in response to local nucleotide signaling. J Biol Chem 285: 34939-34949.
19. Bradbury NA. 2000. Protein kinase-A-mediated secretion of mucin from human colonic epithelial cells. J Cell Physiol 185: 408-415.
20. Brezillon S, Dupuit F, Hinnrasky J, Marchand V, Kalin N, Tummler B, Puchelle E. 1995. Decreased expression of the CFTR protein in remodeled human nasal epithelium from non-cystic fibrosis patients. Lab Invest 72: 191-200.
21. Bridges RJ. 2012. Mechanisms of bicarbonate secretion: Lessons from the airways. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a015016.
22. - channel in adult alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 287: L382-L392.
23. Brockhausen I, Schachter H, Stanley P. 2009. O-GalNAc glycans. In Essentials of glycobiology, 2nd ed. (ed. A Varki, et al.), Chapter 9. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
24. Brodlie M, McKean MC, Johnson GE, Anderson AE, Hilkens CM, Fisher AJ, CorrisPA, Lordan JL, Ward C. 2011. Raised interleukin-17 is immunolocalised to neutrophils in cystic fibrosis lung disease. Eur Respir J 37: 1378-1385.
25. Brugman SM, Taussig LM. 1984. The reproductive system. In Cystic fibrosis(ed. LM Taussig), pp. 323-337. Thieme-Stratton, New York.
26. Bruscia E, Sangiuolo F, Sinibaldi P, Goncz KK, Novelli G, Gruenert DC. 2002. Isolation of CF cell lines corrected at ΔF508-CFTR locus by SFHR-mediated targeting. Gene Ther 9: 683-685.
27. -/- mice. Am J Respir Cell Mol Biol 40: 295-304.
28. Burgoyne RD, Morgan A. 2003. Secretory granule exocytosis. Physiol Rev 83: 581-632.
29. Caramori G, Casolari P, Di GC, Saetta M, Baraldo S, Boschetto P, Ito K, FabbriLM, Barnes PJ, Adcock IM, et al. 2009. MUC5AC expression is increased in bronchial submucosal glands of stable COPD patients. Histopathology 55: 321-331.
30. Carvalho-Oliveira I, Efthymiadou A, Malho R, Nogueira P, Tzetis M, KanavakisE, Amaral MD, Penque D. 2004. CFTR localization in native airway cells and cell lines expressing wild-type or F508del-CFTR by a panel of different antibodies. J Histochem Cytochem 52: 193-203.
31. Castagna I, Roszkowska AM, Fama F, Sinicropi S, Ferreri G. 2001. The eye in cystic fibrosis. Eur J Ophthalmol 11: 9-14.
32. Cervantes-Sandoval I, Serrano-Luna JJ, Meza-Cervantez P, Arroyo R, TsutsumiV, Shibayama M. 2009. Naegleria fowleri induces MUC5AC and pro-inflammatory cytokines in human epithelial cells via ROS production and EGFR activation. Microbiology 155: 3739-3747.
33. Chace KV, Leahy DS, Martin R, Carubelli R, Flux M, Sachdev GP. 1983. Respiratory mucous secretions in patients with cystic fibrosis: Relationship between levels of highly sulfated mucin component and severity of the disease. Clin Chim Acta 132: 143-155.
34. Chan HC, Ruan YC, He Q, Chen MH, Chen H, Xu WM, Chen WY, Xie C, ZhangXH, Zhou Z. 2009. The cystic fibrosis transmembrane conductance regulator in reproductive health and disease. J Physiol 587: 2187-2195.
35. Chandy G, Grabe M, Moore HP, Machen TE. 2001. Proton leak and CFTR in regulation of Golgi pH in respiratory epithelial cells. Am J Physiol Cell Physiol 281: C908-C921.
36. Chen Y, Zhao YH, Di YP, Wu R. 2001a. Characterization of human mucin 5B gene expression in airway epithelium and the genomic clone of the amino-terminal and 5′-flanking region. Am J Respir Cell Mol Biol 25: 542-553.
37. Chen Y, Zhao YH, Wu R. 2001b. Differential regulation of airway mucin gene expression and mucin secretion by extracellular nucleotide triphosphates. Am J Respir Cell Mol Biol 25: 409-417.
38. Chen Y, Nickola TJ, DiFronzo NL, Colberg-Poley AM, Rose MC. 2006. Dexamethasone-mediated repression of MUC5AC gene expression in human lung epithelial cells. Am J Respir Cell Mol Biol 34: 338-347.
39. Chen G, Korfhagen TR, Xu Y, Kitzmiller J, Wert SE, Maeda Y, Gregorieff A, Clevers H, Whitsett JA. 2009. SPDEF is required for mouse pulmonary goblet cell differentiation and regulates a network of genes associated with mucus production. J Clin Invest 119: 2914-2924.
40. Chen EY, Yang N, Quinton PM, Chin WC. 2010. A new role for bicarbonate in mucus formation. Am J Physiol Lung Cell Mol Physiol 299: L542-L549.
41. Chen YA, Watson AM, Williamson CD, Rahimi MK, Liang C, Colberg-Poley AM, Rose MC. 2012. Glucocorticoid receptor and HDAC2 mediate the dexamethasone-induced repression of the MUC5AC gene (submitted).
42. Cheng PW, Radhakrishnan P. 2011. Mucin O-glycan branching enzymes: Structure, function, and gene regulation. Adv Exp Med Biol 705: 465-492.
43. Cheng PW, Boat TF, Cranfill K, Yankaskas JR, Boucher RC. 1989. Increased sulfation of glycoconjugates by cultured nasal epithelial cells from patients with cystic fibrosis. J Clin Invest 84: 68-72.
44. Cheng SH, Gregory RJ, Marshall J, Paul S, Souza DW, White GA, O'Riordan CR, Smith AE. 1990. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63: 827-834.
45. Childers M, Eckel G, Himmel A, Caldwell J. 2007. A new model of cystic fibrosis pathology: Lack of transport of glutathione and its thiocyanate conjugates. Med Hypotheses 68: 101-112.
46. Choi JY, Khansaheb M, Joo NS, Krouse ME, Robbins RC, Weill D, Wine JJ. 2009. Substance P stimulates human airway submucosal gland secretion mainly via a CFTR-dependent process. J Clin Invest 119: 1189-1200.
47. Cholon DM, O'Neal WK, Randell SH, Riordan JR, Gentzsch M. 2010. Modulation of endocytic trafficking and apical stability of CFTR in primary human airway epithelial cultures. Am J Physiol Lung Cell Mol Physiol 298: L304-L314.
48. Chung WC, Ryu SH, Sun H, Zeldin DC, Koo JS. 2009. CREB mediates prostaglandin F2α-induced MUC5AC overexpression. J Immunol 182: 2349-2356.
49. Claass A, Sommer M, de JH, Kalin N, Tummler B. 2000. Applicability of different antibodies for immunohistochemical localization of CFTR in sweat glands from healthy controls and from patients with cystic fibrosis. J Histochem Cytochem 48: 831-837.
50. Cohn JA, Melhus O, Page LJ, Dittrich KL, Vigna SR. 1991. CFTR: Development of high-affinity antibodies and localization in sweat gland. Biochem Biophys Res Commun 181: 36-43.
51. Cohn JA, Strong TV, Picciotto MR, Nairn AC, Collins FS, Fitz JG. 1993. Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells. Gastroenterology 105: 1857-1864.
52. Cone RA. 2009. Barrier properties of mucus. Adv Drug Deliv Rev 61: 75-85.
53. Corfield AP, Myerscough N, Longman R, Sylvester P, Arul S, Pignatelli M. 2000. Mucins and mucosal protection in the gastrointestinal tract: New prospects for mucins in the pathology of gastrointestinal disease. Gut 47: 589-594.
54. Crawford I, Maloney PC, Zeitlin PL, Guggino WB, Hyde SC, Turley H, Gatter KC, Harris A, Higgins CF. 1991. Immunocytochemical localization of the cystic fibrosis gene product CFTR. Proc Natl Acad Sci 88: 9262-9266.
55. Davies JR, Svitacheva N, Lannefors L, Kornfalt R, Carlstedt I. 1999. Identification of MUC5B, MUC5AC and small amounts of MUC2 mucins in cystic fibrosis airway secretions. Biochem J 344: 321-330.
56. Davies WL, Vandenberg JI, Sayeed RA, Trezise AE. 2004. Cardiac expression of the cystic fibrosis transmembrane conductance regulator involves novel exon 1 usage to produce a unique amino-terminal protein. J Biol Chem 279: 15877-15887.
57. Davis CW. 1997. Goblet cells: Physiology and pharmacology. In Airway mucus: Basic mechanisms and clinical perspectives (ed. DF Rogers, MI Lethem), pp. 150-177. Berkhauser, Basel, Switzerland.
58. Davis CW, Dickey BF. 2008. Regulated airway goblet cell mucin secretion. Annu Rev Physiol 70: 487-512.
59. Davril M, Degroote S, Humbert P, Galabert C, Dumur V, Lafitte JJ, Lamblin G, Roussel P. 1999. The sialylation of bronchial mucins secreted by patients suffering from cystic fibrosis or from chronic bronchitis is related to the severity of airway infection. Glycobiology 9: 311-321.
60. Decraene A, Willems-Widyastuti A, Kasran A, De Boeck K, Bullens DM, DupontLJ. 2010. Elevated expression of both mRNA and protein levels of IL-17A in sputum of stable cystic fibrosis patients. Respir Res 11: 177.
61. Dekker J, Strous GJ. 1990. Covalent oligomerization of rat gastric mucin occurs in the rough endoplasmic reticulum, is N-glycosylation-dependent, and precedes initial O-glycosylation. J Biol Chem 265: 18116-18122.
62. Delmotte P, Degroote S, Lafitte JJ, Lamblin G, Perini JM, Roussel P. 2002. Tumor necrosis factor α increases the expression of glycosyltransferases and sulfotransferases responsible for the biosynthesis of sialylated and/or sulfated Lewis x epitopes in the human bronchial mucosa. J Biol Chem 277: 424-431.
63. Desseyn JL, Aubert JP, Porchet N, Laine A. 2000. Evolution of the large secreted gel-forming mucins. Mol Biol Evol 17: 1175-1184.
64. Donaldson SH, Boucher RC. 2007. Sodium channels and cystic fibrosis. Chest 132: 1631-1636.
65. Dorfman R, Nalpathamkalam T, Taylor C, Gonska T, Keenan K, Yuan XW, CoreyM, Tsui LC, Zielenski J, Durie P. 2010. Do common in silico tools predict the clinical consequences of amino-acid substitutions in the CFTR gene? Clin Genet 77: 464-473.
66. Dray-Charier N, Paul A, Veissiere D, Mergey M, Scoazec JY, Capeau J, Brahimi-Horn C, Housset C. 1995. Expression of cystic fibrosis transmembrane conductance regulator in human gallbladder epithelial cells. Lab Invest 73: 828-836.
67. Duchatel F, Muller F, Oury JF, Mennesson B, Boue J, Boue A. 1993. Prenatal diagnosis of cystic fibrosis: Ultrasonography of the gallbladder at 17-19 weeks of gestation. Fetal Diagn Ther 8: 28-36.
68. Dupuit F, Kalin N, Brezillon S, Hinnrasky J, Tummler B, Puchelle E. 1995. CFTR and differentiation markers expression in non-CF and ΔF 508 homozygous CF nasal epithelium. J Clin Invest 96: 1601-1611.
69. Engelhardt JF, Yankaskas JR, Ernst SA, Yang Y, Marino CR, Boucher RC, CohnJA, Wilson JM. 1992. Submucosal glands are the predominant site of CFTR expression in the human bronchus. Nat Genet 2: 240-248.
70. Engelhardt JF, Zepeda M, Cohn JA, Yankaskas JR, Wilson JM. 1994. Expression of the cystic fibrosis gene in adult human lung. J Clin Invest 93: 737-749.
71. Enhorning G, Huldt L, Melen B. 1970. Ability of cervical mucus to act as a barrier against bacteria. Am J Obstet Gynecol 108: 532-537.
72. Evans CM, Koo JS. 2009. Airway mucus: The good, the bad, the sticky. Pharmacol Ther 121: 332-348.
73. Farber S, Shwachman H, Maddock CL. 1943. Pancreatic function and disease in early life. I. Pancreatic enzyme activity and the celiac syndrome. J Clin Invest 22: 827-838.
74. Fischer BM, Voynow JA. 2002. Neutrophil elastase induces MUC5AC gene expression in airway epithelium via a pathway involving reactive oxygen species. Am J Respir Cell Mol Biol 26: 447-452.
75. Florey H. 1930. The secretion of mucus by the colon. Br J Exp Pathol 11: 348-361.
76. Florey H, Carleton HM, Wells AQ. 1932. Mucus secretion in the trachea. Br J Exp Pathol 13: 269-284.
77. Forte TM, Forte JG. 1970. Histochemical staining and characterization of glycoproteins in acid-secreting cells of frog stomach. J Cell Biol 47: 437-452.
78. Freudenberg F, Leonard MR, Liu SA, Glickman JN, Carey MC. 2010. Pathophysiological preconditions promoting mixed "black" pigment plus cholesterol gallstones in a ΔF508 mouse model of cystic fibrosis. Am J Physiol Gastrointest Liver Physiol 299: G205-G214.
79. Fujisawa T, Velichko S, Thai P, Hung LY, Huang F, Wu R. 2009. Regulation of airway MUC5AC expression by IL-1β and IL-17A; the NF-κB paradigm. J Immunol 183: 6236-6243.
80. Fujisawa T, Chang MM, Velichko S, Thai P, Hung LY, Huang F, Phuong N, ChenY, Wu R. 2011. NF-κB mediates IL-1β-and IL-17A-induced MUC5B expression in airway epithelial cells. Am J Respir Cell Mol Biol 45: 246-252.
81. Garcia MA, Yang N, Quinton PM. 2009. Normal mouse intestinal mucus release requires cystic fibrosis transmembrane regulator-dependent bicarbonate secretion. J Clin Invest 119: 2613-2622.
82. Gerken TA, Jamison O, Perrine CL, Collette JC, Moinova H, Ravi L, MarkowitzSD, Shen W, Patel H, Tabak LA. 2011. Emerging paradigms for the initiation of mucin-type protein O-glycosylation by the polypeptide GalNAc transferase family of glycosyltransferases. J Biol Chem 286: 14493-14507.
83. Gibson GA, Hill WG, Weisz OA. 2000. Evidence against the acidification hypothesis in cystic fibrosis. Am J Physiol Cell Physiol 279: C1088-C1099.
84. Goldsworthy NE, Florey H. 1930. Some properties of mucus, with special reference to its antibacterial functions. Br J Exp Pathol 11: 192-208.
85. Gouyer V, Leir SH, Tetaert D, Liu Y, Gottrand F, Harris A, Desseyn JL. 2010. The characterization of the first anti-mouse Muc6 antibody shows an increased expression of the mucin in pancreatic tissue of Cftr-knockout mice. Histochem Cell Biol 133: 517-525.
86. Govindarajan B, Gipson IK. 2010. Membrane-tethered mucins have multiple functions on the ocular surface. Exp Eye Res 90: 655-663.
87. Gray T, Nettesheim P, Loftin C, Koo JS, Bonner J, Peddada S, Langenbach R. 2004. Interleukin-1β-induced mucin production in human airway epithelium is mediated by cyclooxygenase-2, prostaglandin E2 receptors, and cyclic AMP-protein kinase A signaling. Mol Pharmacol 66: 337-346.
88. Groux-Degroote S, Krzewinski-Recchi MA, Cazet A, Vincent A, Lehoux S, Lafitte JJ, Van S, Delannoy P. 2008. IL-6 and IL-8 increase the expression of glycosyltransferases and sulfotransferases involved in the biosynthesis of sialylated and/or sulfated Lewis x epitopes in the human bronchial mucosa. Biochem J 410: 213-223.
89. Gruenert DC, Finkbeiner WE, Widdicombe JH. 1995. Culture and transformation of human airway epithelial cells. Am J Physiol 268: L347-L360.
90. Gum JR Jr., Hicks JW, Toribara NW, Rothe EM, Lagace RE, Kim YS. 1992. The human MUC2 intestinal mucin has cysteine-rich subdomains located both upstream and downstream of its central repetitive region. J Biol Chem 267: 21375-21383.
91. Guo X, Pace RG, Stonebraker JR, Commander CW, Dang AT, Drumm ML, HarrisA, Zou F, Swallow DM, Wright FA, et al. 2011. Mucin variable number tandem repeat polymorphisms and severity of cystic fibrosis lung disease: Significant association with MUC5AC. PLoS ONE 6: e25452.
92. Haggie PM, Verkman AS. 2009. Defective organellar acidification as a cause of cystic fibrosis lung disease: Reexamination of a recurring hypothesis. Am J Physiol Lung Cell Mol Physiol 296: L859-L867.
93. Hattrup CL, Gendler SJ. 2008. Structure and function of the cell surface (tethered) mucins. Annu Rev Physiol 70: 431-457.
94. Hauber HP, Lavigne F, Hung HL, Levitt RC, Hamid Q. 2010. Effect of Th2 type cytokines on hCLCA1 and mucus expression in cystic fibrosis airways. J Cyst Fibros 9: 277-279.
95. Hays SR, Fahy JV. 2006. Characterizing mucous cell remodeling in cystic fibrosis: Relationship to neutrophils. Am J Respir Crit Care Med 174: 1018-1024.
96. Henke MO, Renner A, Huber RM, Seeds MC, Rubin BK. 2004. MUC5AC and MUC5B mucins are decreased in cystic fibrosis airway secretions. Am J Respir Cell Mol Biol 31: 86-91.
97. Henke MO, John G, Germann M, Lindemann H, Rubin BK. 2007. MUC5AC and MUC5B mucins increase in cystic fibrosis airway secretions during pulmonary exacerbation. Am J Respir Crit Care Med 175: 816-821.
98. Henke MO, John G, Rheineck C, Chillappagari S, Naehrlich L, Rubin BK. 2011. Serine proteases degrade airway mucins in cystic fibrosis. Infect Immun 79: 3438-3444.
99. Hewson CA, Edbrooke MR, Johnston SL. 2004. PMA induces the MUC5AC respiratory mucin in human bronchial epithelial cells, via PKC, EGF/TGF-α, Ras/Raf, MEK, ERK and Sp1-dependent mechanisms. J Mol Biol 344: 683-695.
100. Hewson CA, Haas JJ, Bartlett NW, Message SD, Laza-Stanca V, Kebadze T, Caramori G, Zhu J, Edbrooke MR, Stanciu LA, et al. 2010. Rhinovirus induces MUC5AC in a human infection model and in vitro via NF-κB and EGFR pathways. Eur Respir J 36: 1425-1435.
101. Hihnala S, Kujala M, Toppari J, Kere J, Holmberg C, Hoglund P. 2006. Expression of SLC26A3, CFTR and NHE3 in the human male reproductive tract: Role in male subfertility caused by congenital chloride diarrhoea. Mol Hum Reprod 12: 107-111.
102. Hodges CA, Drumm ML. 2009. CF: Tissue by tissue. Pediatr Pulmonol 32: 188-189.
103. Hodges CA, Palmert MR, Drumm ML. 2008. Infertility in females with cystic fibrosis is multifactorial: Evidence from mouse models. Endocrinology 149: 2790-2797.
104. Hollingsworth MA. 1999. Proteins expressed by pancreatic duct cells and their relatives. Ann NY Acad Sci 880: 38-49.
105. Hollingsworth MA, Swanson BJ. 2004. Mucins in cancer: Protection and control of the cell surface. Nat Rev Cancer 4: 45-60.
106. Holmen JM, Karlsson NG, Abdullah LH, Randell SH, Sheehan JK, Hansson GC, Davis CW. 2004. Mucins and their O-glycans from human bronchial epithelial cell cultures. Am J Physiol Lung Cell Mol Physiol 287: L824-L834.
107. Hovenberg HW, Davies JR, Carlstedt I. 1996a. Different mucins are produced by the surface epithelium and the submucosa in human trachea: Identification of MUC5AC as a major mucin from the goblet cells. Biochem J 318: 319-324.
108. Hovenberg HW, Davies JR, Herrmann A, Linden CJ, Carlstedt I. 1996b. MUC5AC, but not MUC2, is a prominent mucin in respiratory secretions. Glycoconj J 13: 839-847.
109. Huang RH, Wang Y, Roth R, Yu X, Purvis AR, Heuser JE, Egelman EH, Sadler JE. 2008. Assembly of Weibel-Palade body-like tubules from N-terminal domains of von Willebrand factor. Proc Natl Acad Sci 105: 482-487.
110. Inoue D, Yamaya M, Kubo H, Sasaki T, Hosoda M, Numasaki M, Tomioka Y, Yasuda H, Sekizawa K, Nishimura H, et al. 2006. Mechanisms of mucin production by rhinovirus infection in cultured human airway epithelial cells. Respir Physiol Neurobiol 154: 484-499.
111. Ishimoto H, Mukae H, Sakamoto N, Amenomori M, Kitazaki T, Imamura Y, Fujita H, Ishii H, Nakayama S, Yanagihara K, et al. 2009. Different effects of telithromycin on MUC5AC production induced by human neutrophil peptide-1 or lipopolysaccharide in NCI-H292 cells compared with azithromycin and clarithromycin. J Antimicrob Chemother 63: 109-114.
112. Jacquot J, Puchelle E, Hinnrasky J, Fuchey C, Bettinger C, Spilmont C, Bonnet N, Dieterle A, Dreyer D, Pavirani A. 1993. Localization of the cystic fibrosis transmembrane conductance regulator in airway secretory glands. Eur Respir J 6: 169-176.
113. Jakab RL, Collaco AM, Ameen NA. 2011. Physiological relevance of cell-specific distribution patterns of CFTR, NKCC1, NBCe1, and NHE3 along the crypt-villus axis in the intestine. Am J Physiol Gastrointest Liver Physiol 300: G82-G98.
114. Jiang X, Hill WG, Pilewski JM, Weisz OA. 1997. Glycosylation differences between a cystic fibrosis and rescued airway cell line are not CFTR dependent. Am J Physiol 273: L913-L920.
115. Johansson ME, Gustafsson JK, Sjoberg KE, Petersson J, Holm L, Sjovall H, Hansson GC. 2010. Bacteria penetrate the inner mucus layer before inflammation in the dextran sulfate colitis model. PLoS ONE 5: e12238.
116. Johansson ME, Ambort D, Pelaseyed T, Schutte A, Gustafsson JK, Ermund A, Subramani DB, Holmen-Larsson JM, Thomsson KA, Bergstrom JH, et al. 2011. Composition and functional role of the mucus layers in the intestine. Cell Mol Life Sci 68: 3635-3641.
117. Jones LC, Moussa L, Fulcher LM, Zhu Y, Hudson EJ, O'Neal WK, Randell SH, Lazarowski ER, Boucher RC, Kreda SM. 2011. VAMP8 is a vesicle SNARE that regulates mucin secretion in airway goblet cells. J Physiol 590: 545-562.
118. Joo NS, Irokawa T, Wu JV, Robbins RC, Whyte RI, Wine JJ. 2002. Absent secretion to vasoactive intestinal peptide in cystic fibrosis airway glands. J Biol Chem 277: 50710-50715.
119. Jouret F, Devuyst O. 2009. CFTR and defective endocytosis: New insights in the renal phenotype of cystic fibrosis. Pflugers Arch 457: 1227-1236.
120. Kalin N, Claass A, Sommer M, Puchelle E, Tummler B. 1999. ΔF508 CFTR protein expression in tissues from patients with cystic fibrosis. J Clin Invest 103: 1379-1389.
121. Kartner N, Augustinas O, Jensen TJ, Naismith AL, Riordan JR. 1992. Mislocalization of ΔF508 CFTR in cystic fibrosis sweat gland. Nat Genet 1: 321-327.
122. Kesimer M, Kirkham S, Pickles RJ, Henderson AS, Alexis NE, DeMaria G, KnightD, Thornton DJ, Sheehan JK. 2008. Tracheobronchial air-liquid interface cell culture: A model for innate mucosal defense of the upper airways? Am J Physiol Lung Cell Mol Physiol 296: L92-L100.
123. Kesimer M, Makhov AM, Griffith JD, Verdugo P, Sheehan JK. 2009a. Unpacking a gel forming mucin: A view of MUC5B organization after granular release. Am J Physiol Lung Cell Mol Physiol 298: L15-L22.
124. Kettle R, Simmons J, Schindler F, Jones P, Dicker T, Dubois G, Giddings J, VanHG, Jones CE. 2010. Regulation of neuregulin 1β1-induced MUC5AC and MUC5B expression in human airway epithelium. Am J Respir Cell Mol Biol 42: 472-481.
125. Kim KC, Hisatsune A, Kim DJ, Miyata T. 2003. Pharmacology of airway goblet cell mucin release. J Pharmacol Sci 92: 301-307.
126. Kim S, Lewis C, Nadel JA. 2011. CCL20/CCR6 feedback exaggerates epidermal growth factor receptor-dependent MUC5AC mucin production in human airway epithelial (NCI-H292) cells. J Immunol 186: 3392-3400.
127. Kirkham S, Sheehan JK, Knight D, Richardson PS, Thornton DJ. 2002. Heterogeneity of airways mucus: Variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B. Biochem J 361: 537-546.
128. Klymiuk N, Mundhenk L, Kraehe K, Wuensch A, Plog S, Emrich D, LangenmayerMC, Stehr M, Holzinger A, Kroner C, et al. 2011. Sequential targeting of CFTR by BAC vectors generates a novel pig model of cystic fibrosis. J Mol Med (Berl) 90: 597-608.
129. Knowles MR, Boucher RC. 2002. Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest 109: 571-577.
130. Kohri K, Ueki IF, Nadel JA. 2002. Neutrophil elastase induces mucin production by ligand-dependent epidermal growth factor receptor activation. Am J Physiol Lung Cell Mol Physiol 283: L531-L540.
131. Kondo M, Finkbeiner WE, Widdicombe JH. 1993. Cultures of bovine tracheal epithelium with differentiated ultrastructure and ion transport. In Vitro Cell Dev Biol 29A: 19-24.
132. Kreda SM, Gentzsch M. 2011. Imaging CFTR protein localization in cultured cells and tissues. Methods Mol Biol 742: 15-33.
133. Kreda SM, Mall M, Mengos A, Rochelle L, Yankaskas J, Riordan JR, Boucher RC. 2005. Characterization of wild-type and ΔF508 cystic fibrosis transmembrane regulator in human respiratory epithelia. Mol Biol Cell 16: 2154-2167.
134. Kreda SM, Okada SF, van Heusden CA, O'Neal W, Gabriel S, Abdullah L, DavisCW, Boucher RC, Lazarowski ER. 2007. Coordinated release of nucleotides and mucin from human airway epithelial Calu-3 cells. J Physiol 584: 245-259.
135. Kreda SM, Seminario-Vidal L, van Heusden CA, O'Neal W, Jones L, Boucher RC, Lazarowski ER. 2010. Receptor-promoted exocytosis of airway epithelial mucin granules containing a spectrum of adenine nucleotides. J Physiol 588: 2255-2267.
136. Kujala M, Hihnala S, Tienari J, Kaunisto K, Hastbacka J, Holmberg C, Kere J, Hoglund P. 2007. Expression of ion transport-associated proteins in human efferent and epididymal ducts. Reproduction 133: 775-784.
137. Kuver R, Klinkspoor JH, Osborne WR, Lee SP. 2000. Mucous granule exocytosis and CFTR expression in gallbladder epithelium. Glycobiology 10: 149-157.
138. Leir SH, Parry S, Palmai-Pallag T, Evans J, Morris HR, Dell A, Harris A. 2005. Mucin glycosylation and sulphation in airway epithelial cells is not influenced by cystic fibrosis transmembrane conductance regulator expression. Am J Respir Cell Mol Biol 32: 453-461.
139. Lemjabbar H, Basbaum C. 2002. Platelet-activating factor receptor and ADAM10 mediate responses to Staphylococcus aureus in epithelial cells. Nat Med 8: 41-46.
140. Lethem MI, Dowell ML, Van Scott M, Yankaskas JR, Egan T, Boucher RC, DavisCW. 1993. Nucleotide regulation of goblet cells in human airway epithelial explants: Normal exocytosis in cystic fibrosis. Am J Respir Cell Mol Biol 9: 315-322.
141. Li JD, Dohrman AF, Gallup M, Miyata S, Gum JR, Kim YS, Nadel JA, Prince A, Basbaum CB. 1997. Transcriptional activation of mucin by Pseudomonas aeruginosa lipopolysaccharide in the pathogenesis of cystic fibrosis lung disease. Proc Natl Acad Sci 94: 967-972.
142. Li D, Gallup M, Fan N, Szymkowski DE, Basbaum CB. 1998. Cloning of the amino-terminal and 5′-flanking region of the human MUC5AC mucin gene and transcriptional up-regulation by bacterial exoproducts. J Biol Chem 273: 6812-6820.
143. Li Y, Martin LD, Spizz G, Adler KB. 2001. MARCKS protein is a key molecule regulating mucin secretion by human airway epithelial cells in vitro. J Biol Chem 276: 40982-40990.
144. Linden SK, Sutton P, Karlsson NG, Korolik V, McGuckin MA. 2008. Mucins in the mucosal barrier to infection. Mucosal Immunol 1: 183-197.
145. Litt M, Khan MA, Chakrin LW, Wardell JR Jr., Christian P. 1974. The viscoelasticity of fractionated canine tracheal mucus. Biorheology 11: 111-117.
146. + channel-overexpressing mice: Role of TNF-α and IL-4Rα signaling, influence of neonatal development, and limited efficacy of glucocorticoid treatment. J Immunol 182: 4357-4367.
147. Livraghi-Butrico A, Kelly EJ, Klem ER, Dang H, Wolfgang MC, Boucher RC, Randell SH, O'Neal WK. 2012. Mucus clearance and MyD88-dependent immunity modulate lung susceptibility to spontaneous bacterial infection and inflammation. Mucosal Immunol doi: 10. 1038/mi. 2012. 17.
148. + absorption produces cystic fibrosis-like lung disease in mice. Nat Med 10: 487-493.
149. Mall M, Kreda SM, Mengos A, Jensen TJ, Hirtz S, Seydewitz HH, Yankaskas J, Kunzelmann K, Riordan JR, Boucher RC. 2004b. The ΔF508 mutation results in loss of CFTR function and mature protein in native human colon. Gastroenterology 126: 32-41.
150. Manson AL, Trezise AE, MacVinish LJ, Kasschau KD, Birchall N, Episkopou V, Vassaux G, Evans MJ, Colledge WH, Cuthbert AW, et al. 1997. Complementation of null CF mice with a human CFTR YAC transgene. EMBO J 16: 4238-4249.
151. Marino CR, Matovcik LM, Gorelick FA, Cohn JA. 1991. Localization of the cystic fibrosis transmembrane conductance regulator in pancreas. J Clin Invest 88: 712-716.
152. Martinez-Anton A, Debolos C, Garrido M, Roca-Ferrer J, Barranco C, Alobid I, Xaubet A, Picado C, Mullol J. 2006. Mucin genes have different expression patterns in healthy and diseased upper airway mucosa. Clin Exp Allergy 36: 448-457.
153. Matsui H, Grubb BR, Tarran R, Randell SH, Gatzy JT, Davis CW, Boucher RC. 1998. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 95: 1005-1015.
154. Matsui H, Verghese MW, Kesimer M, Schwab UE, Randell SH, Sheehan JK, GrubbBR, Boucher RC. 2005. Reduced three-dimensional motility in dehydrated airway mucus prevents neutrophil capture and killing bacteria on airway epithelial surfaces. J Immunol 175: 1090-1099.
155. McAllister F, Henry A, Kreindler JL, Dubin PJ, Ulrich L, Steele C, Finder JD, Pilewski JM, Carreno BM, Goldman SJ, et al. 2005. Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-α and granulocyte colony-stimulating factor in bronchial epithelium: Implications for airway inflammation in cystic fibrosis. J Immunol 175: 404-412.
156. Meyerholz DK, Stoltz DA, Namati E, Ramachandran S, Pezzulo AA, Smith AR, Rector MV, Suter MJ, Kao S, McLennan G, et al. 2010. Loss of cystic fibrosis transmembrane conductance regulator function produces abnormalities in tracheal development in neonatal pigs and young children. Am J Respir Crit Care Med 182: 1251-1261.
157. Monzon ME, Forteza RM, Casalino-Matsuda SM. 2011. MCP-1/CCR2B-dependent loop upregulates MUC5AC and MUC5B in human airway epithelium. Am J Physiol Lung Cell Mol Physiol 300: L204-L215.
158. Moskwa P, Lorentzen D, Excoffon KJ, Zabner J, McCray PB Jr., Nauseef MW, Dupuy C, Banfi B. 2007. A novel host defense system of airways is defective in cystic fibrosis. Am J Respir Crit Care Med 175: 174-183.
159. Mulberg AE, Weyler RT, Altschuler SM, Hyde TM. 1998. Cystic fibrosis transmembrane conductance regulator expression in human hypothalamus. Neuroreport 9: 141-144.
160. Park RW, Grand RJ. 1981. Gastrointestinal manifestations of cystic fibrosis: A review. Gastroenterology 81: 1143-1161.
161. Park JA, He F, Martin LD, Li Y, Chorley BN, Adler KB. 2005. Human neutrophil elastase induces hypersecretion of mucin from well-differentiated human bronchial epithelial cells in vitro via a protein kinase Cδ-mediated mechanism. Am J Pathol 167: 651-661.
162. Park SW, Zhen G, Verhaeghe C, Nakagami Y, Nguyenvu LT, Barczak AJ, KilleenN, Erle DJ. 2009. The protein disulfide isomerase AGR2 is essential for production of intestinal mucus. Proc Natl Acad Sci 106: 6950-6955.
163. Parmley RR, Gendler SJ. 1998. Cystic fibrosis mice lacking Muc1 have reduced amounts of intestinal mucus. J Clin Invest 102: 1798-1806.
164. Penque D, Mendes F, Beck S, Farinha C, Pacheco P, Nogueira P, Lavinha J, Malho R, Amaral MD. 2000. Cystic fibrosis F508del patients have apically localized CFTR in a reduced number of airway cells. Lab Invest 80: 857-868.
165. Peterson M, Leblond CP. 1964. Synthesis of complex carbohydrates in the Golgi region, as shown by radioautography after injection of labeled glucose. J Cell Biol 21: 143-148.
166. Pickles RJ. 2004. Physical and biological barriers to viral vector-mediated delivery of genes to the airway epithelium. Proc Am Thorac Soc 1: 302-308.
167. Puchelle E, Gaillard D, Ploton D, Hinnrasky J, Fuchey C, Boutterin MC, JacquotJ, Dreyer D, Pavirani A, Dalemans W. 1992. Differential localization of the cystic fibrosis transmembrane conductance regulator in normal and cystic fibrosis airway epithelium. Am J Respir Cell Mol Biol 7: 485-491.
168. Quinton PM. 1983. Chloride impermeability in cystic fibrosis. Nature 301: 421-422.
169. Quinton PM. 1990. Cystic fibrosis: A disease in electrolyte transport. FASEB J4: 2709-2717.
170. 3 transport in mucin secretion: Lessons from cystic fibrosis. Am J Physiol Cell Physiol 299: C1222-C1233.
171. Rada B, Gardina P, Myers TG, Leto TL. 2011. Reactive oxygen species mediate inflammatory cytokine release and EGFR-dependent mucin secretion in airway epithelial cells exposed to Pseudomonas pyocyanin. Mucosal Immunol 4: 158-171.
172. Reid CJ, Gould S, Harris A. 1997a. Developmental expression of mucin genes in the human respiratory tract. Am J Respir Cell Mol Biol 17: 592-598.
173. Reid CJ, Hyde K, Ho SB, Harris A. 1997b. Cystic fibrosis of the pancreas: Involvement of MUC6 mucin in obstruction of pancreatic ducts. Mol Med 3: 403-411.
174. Rhodes JM. 1989. Colonic mucus and mucosal glycoproteins: The key to colitis and cancer? Gut 30: 1660-1666.
175. Ribeiro CM, Hurd H, Wu Y, Martino ME, Jones L, Brighton B, Boucher RC, O'NealWK. 2009. Azithromycin treatment alters gene expression in inflammatory, lipid metabolism, and cell cycle pathways in well-differentiated human airway epithelia. PLoS ONE 4: e5806.
176. Riordan JR. 2012. Cold Spring Harb Perspect Med (to be published).
177. Robert R, Thoreau V, Norez C, Cantereau A, Kitzis A, Mettey Y, Rogier C, BecqF. 2004. Regulation of the cystic fibrosis transmembrane conductance regulator channel by β-adrenergic agonists and vasoactive intestinal peptide in rat smooth muscle cells and its role in vasorelaxation. J Biol Chem 279: 21160-21168.
178. Rochwerger L, Buchwald M. 1993. Stimulation of the cystic fibrosis transmembrane regulator expression by estrogen in vivo. Endocrinology 133: 921-930.
179. Rogan MP, Taggart CC, Greene CM, Murphy PG, O'Neill SJ, McElvaney NG. 2004. Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis. J Infect Dis 190: 1245-1253.
180. Rogers CS, Stoltz DA, Meyerholz DK, Ostedgaard LS, Rokhlina T, Taft PF, RoganMP, Pezzulo AA, Karp PH, Itani OA, et al. 2008. Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs. Science 321: 1837-1841.
181. Rose MC. 1988. Epithelial mucous glycoproteins and cystic fibrosis. Horm Metab Res 20: 601-608.
182. Rose MC. 2006. Mucus. In Encyclopedia of respiratory medicine (ed. GJLaurent, SJ Shapiro), pp. 62-66. Academic Press, San Diego.
183. Rose MC, Voynow JA. 2006. Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev 86: 245-278.
184. Rose MC, Lynn WS, Kaufman B. 1979. Resolution of the major components of human lung mucosal gel and their capabilities for reaggregation and gel formation. Biochemistry 18: 4030-4037.
185. Rose MC, Voter WA, Brown CF, Kaufman B. 1984. Structural features of human tracheobronchial mucus glycoprotein. Biochem J 222: 371-377.
186. Rose MC, Brown CF, Jacoby JZ III., Lynn WS, Kaufman B. 1987. Biochemical properties of tracheobronchial mucins from cystic fibrosis and non-cystic fibrosis individuals. Pediatr Res 22: 545-551.
187. Rousseau K, Kirkham S, Johnson L, Fitzpatrick B, Howard M, Adams EJ, RogersDF, Knight D, Clegg P, Thornton DJ. 2008. Proteomic analysis of polymeric salivary mucins: No evidence for MUC19 in human saliva. Biochem J 413: 545-552.
188. Roussel P, Lamblin G. 2003. The glycosylation of airway mucins in cystic fibrosis and its relationship with lung infection by Pseudomonas aeruginosa. Adv Exp Med Biol 535: 17-32.
189. Roussel P, Lamblin G, Degand P. 1975. Heterogeneity of the carbohydrate chains of sulfated bronchial glycoproteins isolated from a patient suffering from cystic fibrosis. J Biol Chem 250: 2114-2122.
190. Roy MG, Rahmani M, Hernandez JR, Alexander SN, Ehre C, Ho SB, Evans CM. 2011. Mucin production during prenatal and postnatal murine lung development. Am J Respir Cell Mol Biol 44: 755-760.
191. Sasaki Y. 2003. New aspects of neurotransmitter release and exocytosis: Rho-kinase-dependent myristoylated alanine-rich C-kinase substrate phosphorylation and regulation of neurofilament structure in neuronal cells. J Pharmacol Sci 93: 35-40.
192. Sasaki M, Ikeda H, Nakanuma Y. 2007. Expression profiles of MUC mucins and trefoil factor family (TFF) peptides in the intrahepatic biliary system: Physiological distribution and pathological significance. Prog Histochem Cytochem 42: 61-110.
193. Schachter H, Dixon GH. 1965. A comparative study of the proteins in normal meconium and in meconium from meconium ileus patients. Can J Biochem Physiol 43: 381-397.
194. Schulz BL, Sloane AJ, Robinson LJ, Prasad SS, Lindner RA, Robinson M, Bye PT, Nielson DW, Harry JL, Packer NH, et al. 2007. Glycosylation of sputum mucins is altered in cystic fibrosis patients. Glycobiology 17: 698-712.
195. Sears PR, Davis CW, Chua M, Sheehan JK. 2011. Mucociliary interactions and mucus dynamics in ciliated human bronchial epithelial cell cultures. Am J Physiol Lung Cell Mol Physiol 301: L181-L186.
196. Seksek O, Biwersi J, Verkman AS. 1996. Evidence against defective trans-Golgi acidification in cystic fibrosis. J Biol Chem 271: 15542-15548.
197. 2+-dependent signaling pathways. J Biol Chem 284: 20638-20648.
198. Sheehan JK, Kirkham S, Howard M, Woodman P, Kutay S, Brazeau C, Buckley J, Thornton DJ. 2004. Identification of molecular intermediates in the assembly pathway of the MUC5AC mucin. J Biol Chem 279: 15698-15705.
199. - secretion. Am J Physiol 266: L493-L501.
200. Singer M, Martin LD, Vargaftig BB, Park J, Gruber AD, Li Y, Adler LB. 2004. A MARCKS-related peptide blocks mucus hypersecretion in a mouse model of asthma. Nat Med 10: 193-196.
201. Smith JJ, Travis SM, Greenberg EP, Welsh MJ. 1996. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85: 229-236.
202. Snouwaert JN, Brigman KK, Latour AM, Malouf NN, Boucher RC, Smithies O, Koller BH. 1992. An animal model for cystic fibrosis made by gene targeting. Science 257: 1083-1088.
203. Song KS, Lee WJ, Chung KC, Koo JS, Yang EJ, Choi JY, Yoon JH. 2003. Interleukin-1β and tumor necrosis factor-α induce MUC5AC overexpression through a mechanism involving ERK/p38 mitogen-activated protein kinases-MSK1-CREB activation in human airway epithelial cells. J Biol Chem 278: 23243-23250.
204. Song KS, Lee TJ, Kim K, Chung KC, Yoon JH. 2008. cAMP-responding element-binding protein and c-Ets1 interact in the regulation of ATP-dependent MUC5AC gene expression. J Biol Chem 283: 26869-26878.
205. Spicer SS, Chakrin LW, Wardell JR Jr., Kendrick W. 1971. Histochemistry of mucosubstances in the canine and human respiratory tract. Lab Invest 25: 483-490.
206. Spurr-Michaud S, Argueso P, Gipson I. 2007. Assay of mucins in human tear fluid. Exp Eye Res 84: 939-950.
207. Strong TV, Boehm K, Collins FS. 1994. Localization of cystic fibrosis transmembrane conductance regulator mRNA in the human gastrointestinal tract by in situ hybridization. J Clin Invest 93: 347-354.
208. Sturgess J. 1982. Morphological characteristics of the bronchial mucosa in cystic fibrosis. In Fluid and electrolyte abnormalities in exocrine glands in cystic fibrosis (ed. Quinton PM, et al.), pp. 254-270. San Francisco Press, San Francisco.
209. Sturgess J, Imrie J. 1982. Quantitative evaluation of the development of tracheal submucosal glands in infants with cystic fibrosis and control infants. Am J Pathol 106: 303-311.
210. Sun X, Sui H, Fisher JT, Yan Z, Liu X, Cho HJ, Joo NS, Zhang Y, Zhou W, Yi Y, et al. 2010. Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis. J Clin Invest 120: 3149-3160.
211. Takeyama K, Dabbagh K, Lee HM, Agusti C, Lausier JA, Ueki IF, Grattan KM, Nadel JA. 1999. Epidermal growth factor system regulates mucin production in airways. Proc Natl Acad Sci 96: 3081-3086.
212. Taylor C, Allen A, Dettmar PW, Pearson JP. 2004. Two rheologically different gastric mucus secretions with different putative functions. Biochim Biophys Acta 1674: 131-138.
213. Ten Hagen KG, Fritz TA, Tabak LA. 2003. All in the family: The UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferases. Glycobiology 13: 1R-16R.
214. Thai P, Loukoianov A, Wachi S, Wu R. 2008. Regulation of airway mucin gene expression. Annu Rev Physiol 70: 405-429.
215. Thomas P, Lukacs G. 2012. Cold Spring Harb Perspect Med (to be published).
216. Thornton DJ, Rousseau K, McGuckin MA. 2007. Structure and function of the polymeric mucins in airways mucus. Annu Rev Physiol 70: 459-486.
217. Tirouvanziam R, Khazaal I, Peault B. 2002. Primary inflammation in human cystic fibrosis small airways. Am J Physiol Lung Cell Mol Physiol 283: L445-L451.
218. Tizzano EF, Buchwald M. 1995. CFTR expression and organ damage in cystic fibrosis. Ann Intern Med 123: 305-308.
219. Tizzano EF, Chitayat D, Buchwald M. 1993. Cell-specific localization of CFTR mRNA shows developmentally regulated expression in human fetal tissues. Hum Mol Genet 2: 219-224.
220. Tizzano EF, O'Brodovich H, Chitayat D, Benichou JC, Buchwald M. 1994a. Regional expression of CFTR in developing human respiratory tissues. Am J Respir Cell Mol Biol 10: 355-362.
221. Tizzano EF, Silver MM, Chitayat D, Benichou JC, Buchwald M. 1994b. Differential cellular expression of cystic fibrosis transmembrane regulator in human reproductive tissues. Clues for the infertility in patients with cystic fibrosis. Am J Pathol 144: 906-914.
222. Trapnell BC, Chu CS, Paakko PK, Banks TC, Yoshimura K, Ferrans VJ, ChernickMS, Crystal RG. 1991. Expression of the cystic fibrosis transmembrane conductance regulator gene in the respiratory tract of normal individuals and individuals with cystic fibrosis. Proc Natl Acad Sci 88: 6565-6569.
223. Trezise AE, Buchwald M. 1991. In vivo cell-specific expression of the cystic fibrosis transmembrane conductance regulator. Nature 353: 434-437.
224. Trezise AE, Chambers JA, Wardle CJ, Gould S, Harris A. 1993. Expression of the cystic fibrosis gene in human foetal tissues. Hum Mol Genet 2: 213-218.
225. 2+ signaling from endoplasmic reticulum. J Biol Chem 284: 9781-9787.
226. Verdugo P. 1991. Mucin exocytosis. Am Rev Respir Dis 144: S33-S37.
227. Verdugo P. 2012. Supramolecular dynamics of mucus. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a009597.
228. Voynow JA, Rubin BK. 2009. Mucins, mucus, and sputum. Chest 135: 505-512.
229. Voynow JA, Young LR, Wang Y, Horger T, Rose MC, Fischer BM. 1999. Neutrophil elastase increases MUC5AC mRNA and protein expression in respiratory epithelial cells. Am J Physiol 276: L835-L843.
230. Voynow JA, Fischer BM, Malarkey DE, Burch LH, Wong T, Longphre M, Ho SB, Foster WM. 2004. Neutrophil elastase induces mucus cell metaplasia in mouse lung. Am J Physiol Lung Cell Mol Physiol 287: L1293-L1302.
231. Voynow JA, Fischer BM, Roberts BC, Proia AD. 2005. Basal-like cells constitute the proliferating cell population in cystic fibrosis airways. Am J Respir Crit Care Med 172: 1013-1018.
232. Welsh MJ, Tsui L-C, Boat TF, Beaudet AL. 1995. Cystic fibrosis. In The metabolic basis of inherited disease, 4th ed. (ed. CR Scriver, et al.), pp. 3799-3876. McGraw-Hill, New York.
233. Wine JJ, Joo NS. 2004. Submucosal glands and airway defense. Proc Am Thorac Soc 1: 47-53.
234. Wine JJ, Joo NS, Choi JY, Cho HJ, Krouse ME, Wu JV, Khansaheb M, Irokawa T, Ianowski J, Hanrahan JW, et al. 2011. Measurement of fluid secretion from intact airway submucosal glands. Methods Mol Biol 742: 93-112.
235. Wu R, Yankaskas J, Cheng E, Knowles MR, Boucher RC. 1985. Growth and differentiation of human nasal epithelial cells in culture: Serum-free, hormone-supplemented medium and proteoglycan synthesis. Am Rev Respir Dis 132: 311-320.
236. Wu R, Martin WR, Robinson CB, St George JA, Plopper CG, Kurland G, Last JA, Cross CE, McDonald RJ, Boucher R. 1990. Expression of mucin synthesis and secretion in human tracheobronchial epithelial cells grown in culture. Am J Respir Cell Mol Biol 3: 467-478.
237. Wu DY, Wu R, Chen Y, Tarasova N, Chang MM. 2007a. PMA stimulates MUC5B gene expression through an Sp1-based mechanism in airway epithelial cells. Am J Respir Cell Mol Biol 37: 589-597.
238. Wu JV, Krouse ME, Wine JJ. 2007b. Acinar origin of CFTR-dependent airway submucosal gland fluid secretion. Am J Physiol Lung Cell Mol Physiol 292: L304-L311.
239. Xia B, Royall JA, Damera G, Sachdev GP, Cummings RD. 2005. Altered O-glycosylation and sulfation of airway mucins associated with cystic fibrosis. Glycobiology 15: 747-775.
240. Xu WM, Shi QX, Chen WY, Zhou CX, Ni Y, Rowlands DK, Yi LG, Zhu H, Ma ZG, Wang XF, et al. 2007. Cystic fibrosis transmembrane conductance regulator is vital to sperm fertilizing capacity and male fertility. Proc Natl Acad Sci 104: 9816-9821.
241. Yang Y, Raper SE, Cohn JA, Engelhardt JF, Wilson JM. 1993. An approach for treating the hepatobiliary disease of cystic fibrosis by somatic gene transfer. Proc Natl Acad Sci 90: 4601-4605.
242. Yankaskas JR, Haizlip JE, Conrad M, Koval D, Lazarowski E, Paradiso AM, Rinehart CA Jr., Sarkadi B, Schlegel R, Boucher RC. 1993. Papilloma virus immortalized tracheal epithelial cells retain a well-differentiated phenotype. Am J Physiol 264: C1219-C1230.
243. Yoshimura K, Nakamura H, Trapnell BC, Chu CS, Dalemans W, Pavirani A, Lecocq JP, Crystal RG. 1991. Expression of the cystic fibrosis transmembrane conductance regulator gene in cells of non-epithelial origin. Nucleic Acids Res 19: 5417-5423.
244. Yu H, Li Q, Kolosov VP, Perelman JM, Zhou X. 2011. Regulation of cigarette smoke-induced mucin expression by neuregulin1β/ErbB3 signalling in human airway epithelial cells. Basic Clin Pharmacol Toxicol 109: 63-72.
245. Yuan-Chen WD, Wu R, Reddy SP, Lee YC, Chang MM. 2007. Distinctive epidermal growth factor receptor/extracellular regulated kinase-independent and-dependent signaling pathways in the induction of airway mucin 5B and mucin 5AC expression by Phorbol 12-Myristate 13-Acetate. Am J Pathol 170: 20-32.
246. Zabner J, Smith JJ, Karp PH, Widdicombe JH, Welsh MJ. 1998. Loss of CFTR chloride channels alters salt absorption by cystic fibrosis airway epithelia in vitro. Mol Cell 2: 397-403.
247. Zalewska A, Zwierz K, Zolkowski K, Gindzienski A. 2000. Structure and biosynthesis of human salivary mucins. Acta Biochim Pol 47: 1067-1079.
248. Zeng W, Lee MG, Yan M, Diaz J, Benjamin I, Marino CR, Kopito R, Freedman S, Cotton C, Muallem S, et al. 1997. Immuno and functional characterization of CFTR in submandibular and pancreatic acinar and duct cells. Am J Physiol 273: C442-C455.
249. Zhang Y, Doranz B, Yankaskas JR, Engelhardt JF. 1995. Genotypic analysis of respiratory mucous sulfation defects in cystic fibrosis. J Clin Invest 96: 2997-3004.
250. Zhou Z, Treis D, Schubert SC, Harm M, Schatterny J, Hirtz S, Duerr J, BoucherRC, Mall MA. 2008. Preventive but not late amiloride therapy reduces morbidity and mortality of lung disease in βENaC-overexpressing mice. Am J Respir Crit Care Med 178: 1245-1256.
251. Zhou Z, Duerr J, Johannesson B, Schubert SC, Treis D, Harm M, Graeber SY, Dalpke A, Schultz C, Mall MA. 2011. The ENaC-overexpressing mouse as a model of cystic fibrosis lung disease. J Cyst Fibros 10: S172-S182.
252. -/- baseline secretion defect reveals source of oligomeric mucins in mouse airways. J Physiol 586: 1977-1992.
253. Zhu L, Lee PK, Lee WM, Zhao Y, Yu D, Chen Y. 2009. Rhinovirus-induced major airway mucin production involves a novel TLR3-EGFR-dependent pathway. Am J Respir Cell Mol Biol 40: 610-619.
254. Zuelzer WW, Newton WA Jr. 1949. The pathogenesis of fibrocystic disease of the pancreas; a study of 36 cases with special reference to the pulmonary lesions. Pediatrics 4: 53-69.
255. Zuhdi Alimam M, Piazza FM, Selby DM, Letwin N, Huang L, Rose MC. 2000. Muc-5/5ac mucin messenger RNA and protein expression is a marker of goblet cell metaplasia in murine airways. Am J Respir Cell Mol Biol 22: 253-260.